{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-022880","form_type":"8-K","ticker":"NAII","cik":"0000787253","company_name":"NATURAL ALTERNATIVES INTERNATIONAL INC","filed_at":"2022-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.148319+00:00","generated_at":"2026-06-23T08:09:51.841287+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Natural Alternatives Q4 net sales up 18% to $52.5M; guides FY2023 sales growth 10-15%","bullets":["Q4 net sales $52.5M (+18.3% YoY); net income $3.1M ($0.52 diluted EPS) vs $3.0M ($0.47) in Q4 FY2021.","Full-year FY2022 net sales $171.0M (-4.2%); net income $10.7M ($1.74 diluted EPS) vs $10.8M ($1.69) in prior year.","Private-label contract manufacturing Q4 up 25.6% to $49.9M; new e-commerce customer drove increase.","CarnoSyn royalty/licensing/raw material sales Q4 down 43.6% to $2.6M due to market/seasonal factors.","Guidance: FY2023 net sales +10-15%, operating income 5-7% of sales; inflation headwinds noted."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-022880","json":"https://secwatch.observer/filing/0001437749-22-022880.json","markdown":"https://secwatch.observer/filing/0001437749-22-022880.md","text":"https://secwatch.observer/filing/0001437749-22-022880.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/787253/000143774922022880/0001437749-22-022880-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/787253/000143774922022880/naii20220921_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T08:09:51.841287+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}